Farallon Capital Management LLC Ascendis Pharma A/S Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Farallon Capital Management LLC holds 1,400 shares of ASND stock, worth $174,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,400

Holding current value

$174,132

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.0 - $153.43 $158,200 - $214,802	1,400 New	1,400 $209,000
Q1 2024 May 15, 2024	BUY	$123.45 - $159.4 $13.5 Million - $17.4 Million	109,000 New	109,000 $16.5 Million
Q2 2021 Aug 13, 2021	SELL	$121.62 - $145.29 $76 Million - $90.8 Million	-625,000 Reduced 62.5%	375,000 $49.3 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $37.8 Million - $45.7 Million	-250,000 Reduced 20.0%	1,000,000 $167 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $14.8 Million - $17 Million	110,000 Added 9.65%	1,250,000 $193 Million
Q2 2020 Aug 14, 2020	SELL	$110.87 - $156.01 $26.2 Million - $36.9 Million	-236,349 Reduced 17.17%	1,140,000 $169 Million
Q1 2020 May 15, 2020	BUY	$97.01 - $145.11 $9.44 Million - $14.1 Million	97,349 Added 7.61%	1,376,349 $155 Million
Q4 2019 Feb 13, 2020	SELL	$91.45 - $139.12 $24.8 Million - $37.7 Million	-271,000 Reduced 17.48%	1,279,000 $178 Million
Q3 2019 Nov 14, 2019	BUY	$95.8 - $118.9 $958,000 - $1.19 Million	10,000 Added 0.65%	1,550,000 $149 Million
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $4.28 Million - $5.28 Million	40,000 Added 2.67%	1,540,000 $177 Million
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $43,691 - $91,382	703 Added 0.05%	1,500,000 $177 Million
Q4 2018 Feb 14, 2019	BUY	$55.16 - $69.67 $2.32 Million - $2.93 Million	42,000 Added 2.88%	1,499,297 $93.9 Million
Q2 2018 Aug 14, 2018	BUY	$58.55 - $73.92 $9.98 Million - $12.6 Million	170,497 Added 13.25%	1,457,297 $96.9 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $68.04 $50.2 Million - $87.6 Million	1,286,800 New	1,286,800 $84.2 Million

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $6.94B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Ascendis Pharma A/S Transaction History